May 28, 2020
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 27, 2020
Alkermes Highlights New Data From Schizophrenia Portfolio at the American Society of Clinical Psychopharmacology 2020 Annual Meeting
May 14, 2020
Alkermes Presents New Data From Schizophrenia Portfolio at Virtual 2020 Congress of the Schizophrenia International Research Society
Mar 04, 2020
Journal of Clinical Psychiatry Publishes Data from Alkermes' Phase 3 ENLIGHTEN-1 Efficacy Study of ALKS 3831 in Patients With Schizophrenia
Feb 20, 2020
Researchers Say Extended Antidepressant Use Creates Physical Dependence
Jan 28, 2020
Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder
Dec 23, 2019
Advisory - One lot of Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream recalled because of a labelling error regarding use in children under two years of age
Nov 28, 2019
Sosei Heptares Announces That the COPD Treatment Ultibro® Breezhaler® has been Included in the National Reimbursement Drug List in China
Nov 19, 2019
Alkermes Submits New Drug Application to U.S. Food and Drug Administration for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder
Aug 16, 2019
IV Ketamine Infusions Dramatically Improve the Quality of Life for Severe Migraine Patient
Jul 25, 2019
TARIS Announces Presentation of Clinical Data for TAR-302 for Overactive Bladder
Jul 15, 2019
Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder
May 23, 2019
Sosei Heptares Notes That a Valid Marketing Authorization Application For QVM149, a Potential New Inhaled Combination Therapy For Asthma, Has Been Filed With the European Medicines Agency
May 01, 2019
TARIS Bio Initiates New Clinical Study of TAR-302 in Overactive Bladder
Mar 28, 2019
Global COPD Drugs Market is projected to display robust growth represented by a CAGR of 2.47% during 2018 - 2023
Mar 27, 2019
Upsher-Smith Launches Generic Version Of Prozac® (fluoxetine) Tablets
Mar 27, 2019
Global COPD Drugs Market by Drug Type, Pipeline Drugs, Region, and Country - Forecast to 2023
Jan 03, 2019
TARIS Appoints Tony Kingsley as President and Chief Executive Officer
Nov 29, 2018
Alkermes Announces Positive Topline Results From ENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With Schizophrenia
Nov 12, 2018
Theravance Biopharma Highlights Expanded COPD Indication for Trelegy Ellipta in Europe